Shive Carey L, Clagett Brian, McCausland Marie R, Mudd Joseph C, Funderburg Nicholas T, Freeman Michael L, Younes Souheil-Antoine, Ferrari Brian M, Rodriguez Benigno, McComsey Grace A, Calabrese Leonard H, Sieg Scott F, Lederman Michael M
*Department of Medicine, Division of Infectious Diseases, Center for AIDS Research, Case Western Reserve University, Cleveland, OH; †National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; ‡School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, OH; §University Hospitals Case Medical Center, Cleveland, OH; and ‖Cleveland Clinic Foundation, Cleveland, OH.
J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):483-92. doi: 10.1097/QAI.0000000000000913.
HIV-infected patients who fail to normalize CD4 T cells despite suppressive antiretroviral therapy have impaired immune homeostasis: diminished naive T-cell numbers, elevated T-cell turnover, senescence, and inflammation.
Blood samples from immune failures (n = 60), immune successes (n = 20), and healthy controls (n = 20) were examined for plasma interleukin (IL)-7 levels, for cellular expression of the IL-7Rα chain (CD127), for the exhaustion and senescence markers programed death 1 (PD-1) and CD57, and for the survival factor Bcl2. Because both inflammatory and homeostatic cytokines can induce T-cell cycling, we also examined the effects of these mediators on exhaustion and senescence markers.
Plasma levels of IL-7 were elevated and both CD4 and CD8 T-cell CD127 expression was decreased in immune failure. Plasma levels of IL-7 correlated directly with naive CD4 T-cell counts in immune success and inversely with T-cell cycling (Ki67) in healthy controls and immune success, but not in immune failure. CD4 T-cell density of PD-1 was increased and Bcl2+ CD4 T cells were decreased in immune failure but not in immune success, whereas the proportion of T cells expressing CD57 was increased in immune failure. PD-1 and CD57 were induced on CD4 but not CD8 T cells by stimulation in vitro with inflammatory IL-1β or homeostatic (IL-7) cytokines.
Perturbation of the IL-7/IL-7 receptor axis, increased T-cell turnover, and increased senescence may reflect dysregulated responses to both homeostatic and inflammatory cytokines in immune failure patients.
尽管接受了抑制性抗逆转录病毒治疗,但未能使CD4 T细胞恢复正常的HIV感染患者存在免疫稳态受损的情况:初始T细胞数量减少、T细胞周转率升高、细胞衰老以及炎症反应。
对免疫治疗失败患者(n = 60)、免疫治疗成功患者(n = 20)和健康对照者(n = 20)的血液样本进行检测,分析血浆白细胞介素(IL)-7水平、IL-7Rα链(CD127)的细胞表达、耗竭和衰老标志物程序性死亡1(PD-1)和CD57,以及生存因子Bcl2。由于炎症和稳态细胞因子均可诱导T细胞循环,我们还研究了这些介质对耗竭和衰老标志物的影响。
免疫治疗失败患者血浆IL-7水平升高,CD4和CD8 T细胞CD127表达均降低。免疫治疗成功患者血浆IL-7水平与初始CD4 T细胞计数直接相关,而在健康对照者和免疫治疗成功患者中,血浆IL-7水平与T细胞循环(Ki67)呈负相关,但在免疫治疗失败患者中并非如此。免疫治疗失败患者中PD-1的CD4 T细胞密度增加,Bcl2 + CD4 T细胞减少,而免疫治疗成功患者则无此现象,然而免疫治疗失败患者中表达CD57的T细胞比例增加。体外使用炎症性IL-1β或稳态(IL-7)细胞因子刺激可诱导CD4而非CD8 T细胞上的PD-1和CD57表达。
IL-7/IL-7受体轴的紊乱、T细胞周转率增加以及衰老加剧可能反映了免疫治疗失败患者对稳态和炎症细胞因子的反应失调。